Markets:

Overview

News

Currencies

International

Treasuries

Innocan Pharma Corp (CSE:INNO)

8.700 -1.210 (-12.21%)

Streaming Delayed Price Updated: 1:37 PM EST, Dec 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Innocan Pharma Corp

Industry Update: Innocan Pharma Accelerates Commercialization in Europe Following Impressive Revenue Growth

May 03, 2023

Via AB Newswire

Topics Intellectual Property

Innovative Delivery Systems Create Unique Opportunities in the Billion-Dollar Pain Market (CSE: INNO)

November 14, 2022

Via AB Newswire

Topics Cannabis

Innocan Pharma Provides an Operational Update

September 21, 2022

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 21, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:...

Via Newsfile

Topics Intellectual Property

Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment

September 09, 2022

A 4-year-old intact male border collie dog with a body weight of 22 kg was suffering from refractory idiopathic (drug-resistant)...

Via Newsfile

Innocan Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022

September 06, 2022

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 6, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Innocan Pharma's CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release of CBD in Large Animals

September 03, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Intellectual Property Supply Chain

Innocan Pharma Received Proceeds of CAD $8.2M from the Exercise of Warrants since January 1, 2021

August 27, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 27, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Supply Chain

Innocan Exercises Option to Enter into a Research and License Agreement with Ramot the Commercial company of the Tel Aviv University

August 18, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 18, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Supply Chain

Innocan Engages Ayurcann Inc. to Manufacture and Distribute Innocan's CBD Topicals in Canada

August 11, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 11, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF)...

Via Newsfile

Topics Supply Chain

Innocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Liposome Platform (LPT)

August 03, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Intellectual Property Supply Chain

Innocan Pharma Announces the Filing of a Patent Application for the Treatment and Prevention of Hair Loss

July 28, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 28, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:...

Via Newsfile

Topics Intellectual Property Supply Chain

Former Israeli Minister of Science and Technology and Highly Influential Venture Capitalist to Join Innocan Pharma's Advisory Committee

July 14, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Artificial Intelligence Supply Chain

Innocan Pharma Announces Filing of International Patent Application for Topical Treatment for Diabetic Symptoms

July 09, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 9, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Intellectual Property Supply Chain

Innocan Pharma and Health Investment Group S.A. Sign Exclusive Distribution Agreement for Poland

July 01, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 1, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Economy Supply Chain

Innocan Pharma's CBD Integrated Anti-Aging Sleeping Mask Demonstrates a Reduction of the Appearance of Wrinkles by up to 28.8% in 4 Weeks of Clinical Study

June 24, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 24, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Supply Chain

Clinical Study Validates Innocan Pharma's SHIR(R) CBD Eye Serum as an Anti-Puffiness Solution

June 16, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 16, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Supply Chain

Innocan Pharma Announces Patent Application for Novel Cannabis-Based Vaginal Moisturizer and Lubricant Treatment

June 14, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Intellectual Property Supply Chain

Innocan Pharma's Liposome Platform Technology Demonstrates a 7-Week Prolonged Release of CBD into Bloodstream in Recent Animal Study

June 11, 2021

Herzliya, Israel and Calgary Alberta--(Newsfile Corp. - June 11, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Intellectual Property Supply Chain

Innocan Pharma Among Leading CBD Pharma Companies to Participate at Lytham Partners Summer 2021 Investor Conference

June 09, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 9, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Supply Chain

Innocan Pharma's CBD Loaded Liposome Platform Technology Receives Positive Results from Recent Animal Study

May 14, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Intellectual Property Supply Chain

Innocan Pharma Engages Lytham Partners to Lead Investor Relations and Shareholder Communication Program

May 10, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 10, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:...

Via Newsfile

Topics Cannabis Supply Chain

Innocan Pharma Announces Trading on the OTCQB Venture Market and DTC Eligibility of Its Common Shares in the United States

May 06, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 6, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Supply Chain

Innocan Pharma and Polyflame Announce an Exclusive Distribution Agreement in France

April 22, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 22, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:...

Via Newsfile

Topics Supply Chain

Richard Serbin, Former Johnson & Johnson's VP and a Leading Global Strategy Advisor in the Healthcare Industry, to Join Innocan Pharma's Scientific Advisory Committee

April 06, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 6, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Via Newsfile

Topics Intellectual Property Supply Chain

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Innocan Pharma Corp (CSE:INNO)

Press Releases about Innocan Pharma Corp

Starting at $3.75/week.

Subscribe Today